Having trouble accessing articles? Reset your cache.

AppyScore: Pivotal trial data

AspenBio said it will not submit a new 510(k) application to FDA for its AppyScore ELISA-based screen/triage blood test for acute appendicitis after data from a U.S. pivotal trial in 859 patients suspected

Read the full 337 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE